Active, not recruitingPhase 3NCT05776277

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

Studying Holt-Oram syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cook MyoSite
Principal Investigator
Ron Jankowski, PhD
Cook Myosite, Inc.
Intervention
Iltamiocel(biological)
Enrollment
200 target
Eligibility
18 years · FEMALE
Timeline
20242027

Study locations (25)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05776277 on ClinicalTrials.gov

Other trials for Holt-Oram syndrome

Additional recruiting or active studies for the same condition.

See all trials for Holt-Oram syndrome

← Back to all trials